<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Case Study: Roche Real-World Evidence Integration for Enhanced Benefit-Risk Analysis | ArcaScience</title>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@300;400;500;600;700&display=swap" rel="stylesheet">
    <style>
        *, *::before, *::after { box-sizing: border-box; margin: 0; padding: 0; }

        body {
            font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
            color: #1a1a2e;
            line-height: 1.7;
            font-size: 11pt;
            background: #ffffff;
        }

        .page-header {
            background: linear-gradient(135deg, #2563EB 0%, #1e40af 100%);
            color: #ffffff;
            padding: 60px 60px 50px;
        }

        .page-header .logo {
            font-size: 14pt;
            font-weight: 700;
            letter-spacing: 1.5px;
            text-transform: uppercase;
            margin-bottom: 30px;
            opacity: 0.9;
        }

        .page-header .label {
            display: inline-block;
            background: rgba(255,255,255,0.2);
            padding: 4px 14px;
            border-radius: 20px;
            font-size: 9pt;
            font-weight: 600;
            letter-spacing: 0.5px;
            text-transform: uppercase;
            margin-bottom: 18px;
        }

        .page-header h1 {
            font-size: 24pt;
            font-weight: 700;
            line-height: 1.2;
            margin-bottom: 15px;
            max-width: 700px;
        }

        .page-header .subtitle {
            font-size: 13pt;
            font-weight: 300;
            opacity: 0.9;
            max-width: 600px;
        }

        .page-header .meta {
            margin-top: 25px;
            font-size: 9pt;
            opacity: 0.75;
        }

        .content {
            max-width: 760px;
            margin: 0 auto;
            padding: 50px 60px;
        }

        h2 {
            font-size: 18pt;
            font-weight: 700;
            color: #2563EB;
            margin-top: 40px;
            margin-bottom: 15px;
            padding-bottom: 8px;
            border-bottom: 2px solid #e5e7eb;
        }

        h3 {
            font-size: 13pt;
            font-weight: 600;
            color: #1e40af;
            margin-top: 25px;
            margin-bottom: 10px;
        }

        p {
            margin-bottom: 14px;
            text-align: justify;
        }

        ul, ol {
            margin-bottom: 14px;
            padding-left: 25px;
        }

        li {
            margin-bottom: 6px;
        }

        .overview-box {
            background: #f0f4ff;
            border-radius: 12px;
            padding: 28px;
            margin: 25px 0;
            display: grid;
            grid-template-columns: 1fr 1fr;
            gap: 20px;
        }

        .overview-item {
            padding: 0;
        }

        .overview-item .label {
            font-size: 9pt;
            font-weight: 600;
            color: #2563EB;
            text-transform: uppercase;
            letter-spacing: 0.5px;
            margin-bottom: 4px;
        }

        .overview-item .value {
            font-size: 11pt;
            color: #1a1a2e;
        }

        .challenge-box {
            background: #fef2f2;
            border: 1px solid #fecaca;
            border-radius: 10px;
            padding: 22px 26px;
            margin: 20px 0;
        }

        .challenge-box h3 {
            color: #b91c1c;
            margin-top: 0;
        }

        .solution-box {
            background: #f0fdf4;
            border: 1px solid #bbf7d0;
            border-radius: 10px;
            padding: 22px 26px;
            margin: 20px 0;
        }

        .solution-box h3 {
            color: #15803d;
            margin-top: 0;
        }

        .results-grid {
            display: grid;
            grid-template-columns: repeat(3, 1fr);
            gap: 15px;
            margin: 25px 0;
        }

        .result-card {
            background: #f0f4ff;
            border-radius: 10px;
            padding: 22px;
            text-align: center;
        }

        .result-card .number {
            font-size: 30pt;
            font-weight: 700;
            color: #2563EB;
            line-height: 1;
        }

        .result-card .unit {
            font-size: 11pt;
            font-weight: 600;
            color: #2563EB;
        }

        .result-card .description {
            font-size: 9pt;
            color: #64748b;
            margin-top: 6px;
            line-height: 1.4;
        }

        .timeline {
            position: relative;
            margin: 25px 0;
            padding-left: 25px;
            border-left: 3px solid #2563EB;
        }

        .timeline-item {
            position: relative;
            margin-bottom: 22px;
            padding-left: 20px;
        }

        .timeline-item::before {
            content: '';
            position: absolute;
            left: -33px;
            top: 5px;
            width: 14px;
            height: 14px;
            background: #2563EB;
            border-radius: 50%;
            border: 3px solid #ffffff;
            box-shadow: 0 0 0 2px #2563EB;
        }

        .timeline-item .week {
            font-size: 9pt;
            font-weight: 700;
            color: #2563EB;
            text-transform: uppercase;
        }

        .timeline-item .title {
            font-weight: 600;
            margin-top: 2px;
        }

        .timeline-item .detail {
            font-size: 10pt;
            color: #475569;
            margin-top: 4px;
        }

        table {
            width: 100%;
            border-collapse: collapse;
            margin: 20px 0;
            font-size: 10pt;
        }

        th {
            background: #2563EB;
            color: #ffffff;
            padding: 10px 14px;
            text-align: left;
            font-weight: 600;
        }

        td {
            padding: 10px 14px;
            border-bottom: 1px solid #e5e7eb;
        }

        tr:nth-child(even) td {
            background: #f8fafc;
        }

        .testimonial {
            background: #f8fafc;
            border-left: 4px solid #2563EB;
            padding: 22px 28px;
            margin: 25px 0;
            border-radius: 0 8px 8px 0;
            font-style: italic;
            font-size: 12pt;
            line-height: 1.6;
        }

        .testimonial .attribution {
            font-style: normal;
            font-size: 10pt;
            color: #64748b;
            margin-top: 12px;
            font-weight: 500;
        }

        .cta-section {
            background: linear-gradient(135deg, #2563EB 0%, #1e40af 100%);
            color: #ffffff;
            padding: 35px;
            border-radius: 12px;
            margin: 40px 0 20px;
            text-align: center;
        }

        .cta-section h3 {
            color: #ffffff;
            font-size: 16pt;
            margin-bottom: 10px;
        }

        .cta-section p {
            text-align: center;
            opacity: 0.9;
        }

        .cta-section .cta-link {
            color: #ffffff;
            font-weight: 600;
            text-decoration: underline;
        }

        .page-footer {
            text-align: center;
            padding: 30px 60px;
            font-size: 8.5pt;
            color: #94a3b8;
            border-top: 1px solid #e5e7eb;
        }

        @media print {
            body { font-size: 10pt; }
            .page-header { padding: 40px; -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .page-header .label { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .content { padding: 30px 40px; }
            .cta-section { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .result-card { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .overview-box { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .challenge-box { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .solution-box { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            .timeline-item::before { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            th { -webkit-print-color-adjust: exact; print-color-adjust: exact; }
            h2, h3 { page-break-after: avoid; }
            table, .testimonial, .results-grid { page-break-inside: avoid; }
            .results-grid { display: block; }
            .result-card { display: inline-block; width: 30%; margin: 5px 1%; }
        }
    </style>
</head>
<body>

<div class="page-header">
    <div class="logo">ArcaScience</div>
    <div class="label">Case Study &mdash; Real-World Evidence</div>
    <h1>Roche: Real-World Evidence Integration for Enhanced Benefit-Risk Analysis</h1>
    <div class="subtitle">How Roche unified 12 real-world data sources with clinical trial data for Ocrevus and Tecentriq, identifying 23 new safety signals and reducing data preparation by 75%</div>
    <div class="meta">Case Study | 2026 | arcascience.ai</div>
</div>

<div class="content">

    <div class="overview-box">
        <div class="overview-item">
            <div class="label">Company</div>
            <div class="value">Roche / Genentech (Top 5 Global Pharmaceutical)</div>
        </div>
        <div class="overview-item">
            <div class="label">Therapeutic Areas</div>
            <div class="value">Neurology (Ocrevus/ocrelizumab) &amp; Oncology (Tecentriq/atezolizumab)</div>
        </div>
        <div class="overview-item">
            <div class="label">Focus</div>
            <div class="value">Real-World Evidence integration into BRA</div>
        </div>
        <div class="overview-item">
            <div class="label">Challenge</div>
            <div class="value">Unifying disparate RWD sources with clinical trial data</div>
        </div>
        <div class="overview-item">
            <div class="label">ArcaScience Modules Used</div>
            <div class="value">Data Intelligence, Decision Intelligence, Automated Outputs</div>
        </div>
        <div class="overview-item">
            <div class="label">Timeline</div>
            <div class="value">16-week implementation</div>
        </div>
    </div>

    <h2>The Challenge</h2>

    <div class="challenge-box">
        <h3>Fragmented Real-World Data Across Multiple Sources</h3>
        <p>
            Roche recognized the strategic value of integrating real-world evidence into their benefit-risk assessments but faced significant technical and methodological challenges. Real-world data was scattered across 12+ sources&mdash;claims databases, EHR systems, registries, and patient support programs&mdash;with different formats, terminologies, and quality standards. Manual data harmonization took months and produced inconsistent results. Regulatory agencies were increasingly requesting RWE to supplement clinical trial data, but Roche lacked a scalable framework to deliver this systematically across their portfolio.
        </p>
    </div>

    <h2>The Solution</h2>

    <div class="solution-box">
        <h3>ArcaScience Platform Deployment</h3>
        <p>
            ArcaScience deployed its Data Intelligence module to create an automated RWE integration pipeline, harmonizing 12 real-world data sources with clinical trial databases for continuous, enriched benefit-risk analysis.
        </p>
    </div>

    <h2>Implementation Process</h2>

    <div class="timeline">
        <div class="timeline-item">
            <div class="week">Weeks 1&ndash;3</div>
            <div class="title">Data Source Mapping</div>
            <div class="detail">Inventoried and assessed all 12 RWD sources. Mapped data elements to common data model (OMOP CDM). Established data quality scoring and validation rules.</div>
        </div>
        <div class="timeline-item">
            <div class="week">Weeks 4&ndash;7</div>
            <div class="title">Integration Pipeline Build</div>
            <div class="detail">Built automated ETL pipelines for each data source. Implemented AI-powered terminology harmonization (ICD-10, MedDRA, SNOMED-CT mapping). Created unified patient-level longitudinal records.</div>
        </div>
        <div class="timeline-item">
            <div class="week">Weeks 8&ndash;11</div>
            <div class="title">Signal Detection &amp; Analysis</div>
            <div class="detail">Deployed cross-source signal detection algorithms. Identified 23 new safety signals not visible in individual data sources alone. Characterized signal strength using multi-source triangulation methodology.</div>
        </div>
        <div class="timeline-item">
            <div class="week">Weeks 12&ndash;14</div>
            <div class="title">BRA Enhancement</div>
            <div class="detail">Integrated RWE findings into existing MCDA benefit-risk frameworks. Generated enhanced PBRER sections incorporating RWE. Created regulatory-ready data packages for health authority requests.</div>
        </div>
        <div class="timeline-item">
            <div class="week">Weeks 15&ndash;16</div>
            <div class="title">Validation &amp; Handover</div>
            <div class="detail">Validated results against known safety signals (100% sensitivity). Trained Roche's epidemiology and PV teams. Established ongoing automated monitoring.</div>
        </div>
    </div>

    <h2>Results</h2>

    <div class="results-grid">
        <div class="result-card">
            <div class="number">75<span class="unit">%</span></div>
            <div class="description">Reduction in data<br>preparation time</div>
        </div>
        <div class="result-card">
            <div class="number">12</div>
            <div class="unit">sources</div>
            <div class="description">Unified real-world<br>data sources</div>
        </div>
        <div class="result-card">
            <div class="number">23</div>
            <div class="unit">signals</div>
            <div class="description">New safety signals<br>identified</div>
        </div>
    </div>

    <p>
        <strong>Additional result:</strong> 40% faster PBRER completion, reducing turnaround from 14 weeks to 8.4 weeks.
    </p>

    <h3>Quantitative Outcomes</h3>

    <table>
        <thead>
            <tr>
                <th>Metric</th>
                <th>Before ArcaScience</th>
                <th>After ArcaScience</th>
            </tr>
        </thead>
        <tbody>
            <tr>
                <td>RWD preparation time</td>
                <td>4&ndash;6 months per analysis</td>
                <td>2&ndash;4 weeks automated</td>
            </tr>
            <tr>
                <td>Data sources integrated</td>
                <td>2&ndash;3 (manually selected)</td>
                <td>12 (comprehensive)</td>
            </tr>
            <tr>
                <td>Signal detection from RWD</td>
                <td>Ad hoc, retrospective</td>
                <td>Continuous, automated</td>
            </tr>
            <tr>
                <td>New signals per year from RWE</td>
                <td>3&ndash;5</td>
                <td>23 in first cycle</td>
            </tr>
            <tr>
                <td>PBRER completion time</td>
                <td>14 weeks</td>
                <td>8.4 weeks (40% faster)</td>
            </tr>
            <tr>
                <td>RWE regulatory submissions</td>
                <td>2 per year</td>
                <td>8 per year</td>
            </tr>
        </tbody>
    </table>

    <div class="testimonial">
        "ArcaScience solved a problem we'd been struggling with for years. Integrating real-world evidence into our benefit-risk assessments at scale seemed impossible with manual processes. Their platform made it not just possible but routine&mdash;and the signal detection capabilities exceeded our expectations."
        <div class="attribution">&mdash; VP, Real-World Evidence &amp; Epidemiology, Roche</div>
    </div>

    <div class="testimonial">
        "Finding 23 new safety signals from integrated RWD analysis was a breakthrough. Several of these signals informed labeling updates and risk management strategies that we would not have identified from clinical trial data alone. This is the future of pharmacovigilance."
        <div class="attribution">&mdash; Global Head of Patient Safety, Roche/Genentech</div>
    </div>

    <h2>Key Takeaways</h2>
    <ol>
        <li><strong>Real-world evidence integration at scale requires automated data harmonization</strong>&mdash;manual approaches cannot keep pace with regulatory expectations.</li>
        <li><strong>Multi-source signal triangulation identifies safety signals invisible to single-source analysis,</strong> providing a more complete safety picture.</li>
        <li><strong>The 75% reduction in data preparation time transforms RWE</strong> from a special project into routine PV operations.</li>
        <li><strong>Regulatory agencies increasingly value RWE-enriched BRAs,</strong> making scalable integration a competitive necessity.</li>
        <li><strong>Continuous automated monitoring replaces periodic retrospective analyses,</strong> enabling proactive rather than reactive safety management.</li>
    </ol>

    <div class="cta-section">
        <h3>Ready to Transform Your Benefit-Risk Strategy?</h3>
        <p>Learn how ArcaScience can support your next regulatory submission with AI-driven benefit-risk analysis.</p>
        <p style="margin-top: 15px; margin-bottom: 0;">
            <a class="cta-link" href="https://arcascience.ai/contact">Schedule a Consultation</a> &nbsp;|&nbsp;
            <a class="cta-link" href="mailto:info@arcascience.ai">info@arcascience.ai</a>
        </p>
    </div>

</div>

<div class="page-footer">
    &copy; 2026 ArcaScience. All rights reserved. | arcascience.ai<br>
    This case study is based on an actual client engagement with certain details anonymized and modified to protect confidentiality.
</div>

</body>
</html>
